Ernst Holler Selected Research

Infections

1/2021	Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
1/2021	Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
1/2020	The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
10/2019	Long-term follow-up of rituximab in treatment of chronic graft-versus-host disease-single center experience.
5/2017	Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.
8/2015	Donor Nucleotide-Binding Oligomerization-Containing Protein 2 (NOD2) Single Nucleotide Polymorphism 13 Is Associated with Septic Shock after Allogeneic Stem Cell Transplantation.
5/2014	Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
1/2012	The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection.
9/2011	Danger signals activating innate immunity in graft-versus-host disease.
7/2007	Impact of NOD2/CARD15 haplotypes on the outcome after kidney transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ernst Holler Research Topics

Disease

77	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 09/2002
22	Bronchiolitis Obliterans Syndrome 03/2021 - 02/2006
16	Infections 01/2021 - 03/2002
15	Neoplasms (Cancer) 11/2021 - 02/2007
10	Inflammation (Inflammations) 01/2022 - 01/2007
10	Leukemia 11/2019 - 02/2006
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2007
7	Crohn Disease (Crohn's Disease) 01/2015 - 08/2004
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2002
6	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 02/2007
5	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2013 - 11/2002
4	Pneumonia (Pneumonitis) 01/2021 - 08/2004
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 07/2008
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2016
3	Multiple Myeloma 11/2019 - 02/2007
3	Necrosis 02/2014 - 12/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2010 - 04/2007
3	Hemolytic Anemia 02/2006 - 11/2002
2	Communicable Diseases (Infectious Diseases) 01/2021 - 10/2003
2	Colitis 01/2021 - 01/2018
2	Polyneuropathies (Polyneuropathy) 01/2021 - 01/2012
2	Nephritis 09/2020 - 11/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 05/2009
2	Lymphoma (Lymphomas) 01/2016 - 12/2009
2	Hematologic Diseases (Blood Diseases) 01/2016 - 01/2012
2	Sepsis (Septicemia) 10/2013 - 07/2004
2	Neutropenia 01/2011 - 03/2002
2	Thrombocytopenia (Thrombopenia) 01/2007 - 11/2002
2	Fever (Fevers) 07/2006 - 03/2002
2	Lung Injury 03/2005 - 08/2004
2	Thrombosis (Thrombus) 09/2004 - 11/2002
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Myasthenia Gravis 01/2021
1	Carcinogenesis 12/2020
1	Vasculitis (Vasculitides) 09/2020
1	Pathologic Complete Response 01/2020
1	Dysbiosis 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2006
9	SteroidsIBA 03/2021 - 02/2006
5	CytokinesIBA 08/2005 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 02/2010
4	Biological ProductsIBA 02/2011 - 09/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 03/2002
4	DNA (Deoxyribonucleic Acid)IBA 02/2010 - 08/2004
3	Busulfan (Busulfex)FDA Link 01/2022 - 12/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2018
3	Thomsen-Friedenreich antibodiesIBA 02/2020 - 09/2009
3	GlobulinsIBA 02/2020 - 09/2009
3	fludarabineIBA 01/2020 - 07/2008
3	NucleotidesIBA 08/2015 - 07/2007
3	Methotrexate (Mexate)FDA LinkGeneric 10/2012 - 09/2004
3	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 04/2007
3	Interleukin-6 (Interleukin 6)IBA 06/2010 - 03/2002
3	NF-kappa B (NF-kB)IBA 09/2007 - 08/2004
3	AntigensIBA 02/2007 - 11/2005
2	treosulfanIBA 01/2022 - 01/2020
2	Volatile Fatty AcidsIBA 01/2022 - 01/2021
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 12/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2020 - 11/2002
2	LigandsIBA 01/2018 - 08/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2017 - 05/2014
2	Antimicrobial PeptidesIBA 01/2017 - 08/2011
2	Hemoglobins (Hemoglobin)IBA 02/2016 - 01/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2015 - 03/2010
2	C-Reactive ProteinIBA 01/2015 - 07/2006
2	Bacterial DNAIBA 02/2014 - 08/2011
2	Pharmaceutical PreparationsIBA 05/2013 - 10/2010
2	CreatinineIBA 10/2012 - 12/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2012 - 09/2009
2	ChemokinesIBA 02/2011 - 04/2009
2	Interleukin-10 (Interleukin 10)IBA 06/2010 - 12/2004
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 06/2010 - 03/2002
2	InterleukinsIBA 12/2004 - 09/2002
2	Interferon-gamma (Interferon, gamma)IBA 12/2004 - 11/2002
1	Interleukin-22 (IL-22)IBA 01/2022
1	Butyrates (Butyrate)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	heparanaseIBA 11/2021
1	EnzymesIBA 11/2021
1	Abatacept (Orencia)FDA Link 03/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	letermovirIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 04/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 02/2020
1	montelukast (Singulair)FDA Link 02/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2020
1	Rituximab (Mabthera)FDA Link 10/2019

Therapy/Procedure

42	Stem Cell Transplantation 01/2022 - 11/2002
41	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2004
20	Therapeutics 01/2021 - 10/2003
19	Transplantation 01/2022 - 11/2002
15	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 05/2004
14	Cell Transplantation 01/2022 - 07/2008
7	Homologous Transplantation 11/2019 - 07/2011
6	Drug Therapy (Chemotherapy) 01/2021 - 03/2002
4	Salvage Therapy 03/2021 - 10/2012
1	Withholding Treatment 01/2020
1	Donor Selection 11/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2019